An antisense oligonucleotide demonstrated a favorable safety profile and its disease-halting effect in one patient suggests ...

Povicaine, launched in late 2024, has “become a staple in our practice,” Brandon D. Ayres, MD, said in this Healio Video Perspective from Kiawah Eye.

Consuming a noninflammatory diet increased OS for patients with late-stage colon cancer, according to findings from a large, prospective cohort study presented at ASCO Annual Meeting.Of note, regular ...